List view / Grid view

Terumo Blood and Cell Technologies

 

article

Overcoming operational challenges in CGT manufacturing with AI

18 September 2024 | By

In this Q&A, Dalip Sethi, scientific lead for Terumo Blood and Cell Technologies, Cell Therapy Technologies and Innovation portfolio, discusses the integration of AI into CGT manufacturing processes to enhance operational efficiency and accelerate treatment access. He also elucidates the strategies that are being considered to overcome hurdles when implementing…